TSLA Tesla | $308.58
+4.6% | 6/5/2025 | Target Set by | Wedbush | Analyst Dan Ives | | $500.00 | Medium | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 6/5/2025 |
DOCU DocuSign | $78.58
+4.4% | 6/6/2025 | Target Lowered by | Wedbush | Analyst Daniel Ives | Neutral -> Neutral | $100.00 -> $85.00 | Low | View details for Wedbush rating of DocuSign (NASDAQ:DOCU) on 6/6/2025 |
RBRK Rubrik | $93.27
-4.7% | 6/6/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $80.00 -> $120.00 | Low | View details for Wedbush rating of Rubrik (NYSE:RBRK) on 6/6/2025 |
PL Planet Labs PBC | $5.85
+0.2% | 6/5/2025 | Target Raised by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $5.00 -> $7.00 | High | View details for Wedbush rating of Planet Labs PBC (NYSE:PL) on 6/5/2025 |
LGIH LGI Homes | $51.31
+4.8% | 6/5/2025 | Target Lowered by | Wedbush | Analyst Jay McCanless | Neutral -> Neutral | $100.00 -> $93.00 | Low | View details for Wedbush rating of LGI Homes (NASDAQ:LGIH) on 6/5/2025 |
MDB MongoDB | $217.23
-1.3% | 6/5/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $300.00 | High | View details for Wedbush rating of MongoDB (NASDAQ:MDB) on 6/5/2025 |
PHVS Pharvaris | $18.03
+7.4% | 6/5/2025 | Reiterated by | Wedbush | Analyst Laura Chico | Outperform -> Outperform | $27.00 | Medium | View details for Wedbush rating of Pharvaris (NASDAQ:PHVS) on 6/5/2025 |
TLX Telix Pharmaceuticals Limited American Depositary Shares | $16.91
+0.8% | 6/5/2025 | Initiated by | Wedbush | Analyst David Nierengarten | Outperform | $22.00 | Medium | View details for Wedbush rating of Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) on 6/5/2025 |
VRNT Verint Systems | $19.11
+0.1% | 6/4/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $30.00 | High | View details for Wedbush rating of Verint Systems (NASDAQ:VRNT) on 6/4/2025 |
CRWD CrowdStrike | $464.39
-0.9% | 6/3/2025 | Target Raised by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $475.00 -> $525.00 | Low | View details for Wedbush rating of CrowdStrike (NASDAQ:CRWD) on 6/3/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
PEGA Pegasystems | $102.04
-0.4% | 6/3/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $125.00 | Low | View details for Wedbush rating of Pegasystems (NASDAQ:PEGA) on 6/3/2025 |
BPMC Blueprint Medicines | $127.97
+0.1% | 6/2/2025 | Downgraded by | Wedbush | Analyst David Nierengarten | Outperform -> Neutral | $128.00 -> $129.00 | High | View details for Wedbush rating of Blueprint Medicines (NASDAQ:BPMC) on 6/2/2025 |
NTAP NetApp | $103.06
-3.0% | 5/30/2025 | Reiterated by | Wedbush | - | Neutral | $110.00 | Medium | View details for Wedbush rating of NetApp (NASDAQ:NTAP) on 5/30/2025 |
ZS Zscaler | $299.90
-1.0% | 5/30/2025 | Target Raised by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $240.00 -> $300.00 | High | View details for Wedbush rating of Zscaler (NASDAQ:ZS) on 5/30/2025 |
KROS Keros Therapeutics | $14.09
-6.3% | 5/30/2025 | Reiterated by | Wedbush | Analyst Y. Zhong | Neutral -> Neutral | $15.00 | Medium | View details for Wedbush rating of Keros Therapeutics (NASDAQ:KROS) on 5/30/2025 |
ESTC Elastic | $85.82
-0.7% | 5/30/2025 | Target Lowered by | Wedbush | Analyst D. Ives | Outperform -> Outperform | $135.00 -> $110.00 | Medium | View details for Wedbush rating of Elastic (NYSE:ESTC) on 5/30/2025 |
BBY Best Buy | $72.75
-0.4% | 5/30/2025 | Target Lowered by | Wedbush | Analyst M. Mccartney | Neutral -> Neutral | $75.00 -> $70.00 | Low | View details for Wedbush rating of Best Buy (NYSE:BBY) on 5/30/2025 |
PSTG Pure Storage | $55.55
+0.5% | 5/29/2025 | Reiterated by | Wedbush | - | Outperform | $70.00 | Medium | View details for Wedbush rating of Pure Storage (NYSE:PSTG) on 5/29/2025 |
NVDA NVIDIA | $142.63
+0.6% | 5/29/2025 | Reiterated by | Wedbush | - | Outperform -> Outperform | | Low | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 5/29/2025 |
NTLA Intellia Therapeutics | $8.28
+2.3% | 5/29/2025 | Reiterated by | Wedbush | - | Neutral | $10.00 -> $7.00 | High | View details for Wedbush rating of Intellia Therapeutics (NASDAQ:NTLA) on 5/29/2025 |
ANAB AnaptysBio | $23.19
-2.2% | 5/29/2025 | Reiterated by | Wedbush | - | Outperform | $40.00 | High | View details for Wedbush rating of AnaptysBio (NASDAQ:ANAB) on 5/29/2025 |
ORIC ORIC Pharmaceuticals | $9.86
+5.8% | 5/29/2025 | Reiterated by | Wedbush | - | Outperform | $20.00 | High | View details for Wedbush rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 5/29/2025 |
YMAB Y-mAbs Therapeutics | $5.08
-3.6% | 5/28/2025 | Reiterated by | Wedbush | - | Outperform | $21.00 -> $18.00 | Low | View details for Wedbush rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 5/28/2025 |
EQR Equity Residential | $69.32
+1.2% | 5/28/2025 | Reiterated by | Wedbush | - | Neutral | $75.00 | Medium | View details for Wedbush rating of Equity Residential (NYSE:EQR) on 5/28/2025 |
ITOS iTeos Therapeutics | $10.04
-1.3% | 5/28/2025 | Downgraded by | Wedbush | Analyst David Nierengarten | Outperform -> Neutral | $10.00 -> $12.00 | High | View details for Wedbush rating of iTeos Therapeutics (NASDAQ:ITOS) on 5/28/2025 |
ANET Arista Networks | $96.93
-0.3% | 5/28/2025 | Initiated by | Wedbush | - | Outperform | | Low | View details for Wedbush rating of Arista Networks (NYSE:ANET) on 5/28/2025 |
ACRS Aclaris Therapeutics | $1.49
-2.6% | 5/28/2025 | Initiated by | Wedbush | Analyst Martin Fan | Outperform | $8.00 | High | View details for Wedbush rating of Aclaris Therapeutics (NASDAQ:ACRS) on 5/28/2025 |
UBS UBS Group | $32.93
-2.0% | 5/27/2025 | Reiterated by | Wedbush | - | Neutral -> Neutral | | Low | View details for Wedbush rating of UBS Group (NYSE:UBS) on 5/27/2025 |
CVCO Cavco Industries | $425.23
-0.8% | 5/27/2025 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $550.00 | High | View details for Wedbush rating of Cavco Industries (NASDAQ:CVCO) on 5/27/2025 |
NVDA NVIDIA | $142.63
+0.6% | 5/23/2025 | Downgraded by | Wedbush | - | Outperform -> Cautious | | Low | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 5/23/2025 |
BCAX Bicara Therapeutics | $11.48
-0.2% | 5/23/2025 | Reiterated by | Wedbush | Analyst D. Nierengarten | Outperform | $30.00 | High | View details for Wedbush rating of Bicara Therapeutics (NASDAQ:BCAX) on 5/23/2025 |
BBY Best Buy | $72.75
-0.4% | 5/23/2025 | Upgraded by | Wedbush | Analyst Alicia Reese | Hold | $75.00 | Low | View details for Wedbush rating of Best Buy (NYSE:BBY) on 5/23/2025 |
TSLA Tesla | $308.58
+4.6% | 5/23/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $350.00 -> $500.00 | Low | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 5/23/2025 |
OKLO Oklo | $54.63
+8.6% | 5/23/2025 | Target Raised by | Wedbush | Analyst D. Ives | Outperform -> Outperform | $45.00 -> $55.00 | High | View details for Wedbush rating of Oklo (NYSE:OKLO) on 5/23/2025 |
NVDA NVIDIA | $142.63
+0.6% | 5/22/2025 | Reiterated by | Wedbush | Analyst Matt Bryson | Outperform -> Outperform | $175.00 | Low | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 5/22/2025 |
VIGL Vigil Neuroscience | $7.88
| 5/22/2025 | Downgraded by | Wedbush | Analyst Laura Chico | Strong-Buy -> Hold | $13.00 -> $8.00 | N/A | View details for Wedbush rating of Vigil Neuroscience (NASDAQ:VIGL) on 5/22/2025 |
MSFT Microsoft | $472.75
+0.5% | 5/21/2025 | Reiterated by | Wedbush | - | Outperform -> Outperform | | Low | View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 5/21/2025 |
LOGI Logitech International | $85.98
+0.9% | 5/21/2025 | Reiterated by | Wedbush | Analyst A. Reese | Outperform | $100.00 | Low | View details for Wedbush rating of Logitech International (NASDAQ:LOGI) on 5/21/2025 |
STX Seagate Technology | $130.17
+2.5% | 5/21/2025 | Reiterated by | Wedbush | - | Outperform | $140.00 | High | View details for Wedbush rating of Seagate Technology (NASDAQ:STX) on 5/21/2025 |
HOV Hovnanian Enterprises | $98.16
+4.4% | 5/20/2025 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral | $120.00 | High | View details for Wedbush rating of Hovnanian Enterprises (NYSE:HOV) on 5/20/2025 |
Why Elon put $51 million into this (Ad) Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists [See The Details Here] |
TOL Toll Brothers | $109.57
+2.1% | 5/20/2025 | Reiterated by | Wedbush | - | Outperform -> Outperform | | Medium | View details for Wedbush rating of Toll Brothers (NYSE:TOL) on 5/20/2025 |
RITM Rithm Capital | $11.25
-0.8% | 5/19/2025 | Reiterated by | Wedbush | Analyst Jay McCanless | Outperform -> Outperform | $14.00 -> $14.00 | Low | View details for Wedbush rating of Rithm Capital (NYSE:RITM) on 5/19/2025 |
NTLA Intellia Therapeutics | $8.28
+2.3% | 5/19/2025 | Reiterated by | Wedbush | Analyst David Nierengarten | Neutral -> Neutral | $10.00 -> $10.00 | Low | View details for Wedbush rating of Intellia Therapeutics (NASDAQ:NTLA) on 5/19/2025 |
KMX CarMax | $67.18
+2.2% | 5/19/2025 | Reiterated by | Wedbush | Analyst Scott Devitt | Outperform -> Outperform | $90.00 -> $90.00 | Medium | View details for Wedbush rating of CarMax (NYSE:KMX) on 5/19/2025 |
SE SEA | $164.67
-0.6% | 5/14/2025 | Reiterated by | Wedbush | - | Outperform -> Outperform | | Low | View details for Wedbush rating of SEA (NYSE:SE) on 5/14/2025 |
OKLO Oklo | $54.63
+8.6% | 5/14/2025 | Target Set by | Wedbush | Analyst D. Ives | Outperform -> Outperform | $45.00 | High | View details for Wedbush rating of Oklo (NYSE:OKLO) on 5/14/2025 |
INZY Inozyme Pharma | $3.98
-0.3% | 5/16/2025 | Downgraded by | Wedbush | Analyst D. Nierengarten | Strong-Buy -> Hold | | Low | View details for Wedbush rating of Inozyme Pharma (NASDAQ:INZY) on 5/16/2025 |
SLDB Solid Biosciences | $4.62
+1.8% | 5/16/2025 | Target Lowered by | Wedbush | Analyst L. Chico | Outperform -> Outperform | $18.00 -> $17.00 | High | View details for Wedbush rating of Solid Biosciences (NASDAQ:SLDB) on 5/16/2025 |
GOSS Gossamer Bio | $1.33
| 5/16/2025 | Reiterated by | Wedbush | Analyst Laura Chico | Outperform -> Outperform | $4.00 -> $4.00 | High | View details for Wedbush rating of Gossamer Bio (NASDAQ:GOSS) on 5/16/2025 |
RCKT Rocket Pharmaceuticals | $3.02
-1.6% | 5/16/2025 | Reiterated by | Wedbush | Analyst Y. Zhong | Outperform -> Outperform | $32.00 -> $32.00 | Low | View details for Wedbush rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 5/16/2025 |
TVTX Travere Therapeutics | $14.91
-2.7% | 5/16/2025 | Reiterated by | Wedbush | Analyst Laura Chico | Outperform -> Outperform | $30.00 -> $30.00 | High | View details for Wedbush rating of Travere Therapeutics (NASDAQ:TVTX) on 5/16/2025 |
DT Dynatrace | $54.24
-1.4% | 5/16/2025 | Reiterated by | Wedbush | Analyst Taz Koujalgi | Outperform -> Outperform | $67.00 -> $67.00 | Low | View details for Wedbush rating of Dynatrace (NYSE:DT) on 5/16/2025 |
TMC TMC the metals | $4.37
+6.6% | 5/16/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Neutral -> Neutral | $6.00 -> $6.00 | High | View details for Wedbush rating of TMC the metals (NASDAQ:TMC) on 5/16/2025 |
XOS XOS | $3.25
+3.2% | 5/16/2025 | Target Lowered by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $8.00 -> $6.00 | Medium | View details for Wedbush rating of XOS (NASDAQ:XOS) on 5/16/2025 |
NICE NICE | $175.42
-0.7% | 5/16/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $200.00 -> $200.00 | Low | View details for Wedbush rating of NICE (NASDAQ:NICE) on 5/16/2025 |
LAC Lithium Americas | $2.78
+3.0% | 5/16/2025 | Reiterated by | Wedbush | Analyst D. Ives | Neutral -> Neutral | $5.00 -> $5.00 | High | View details for Wedbush rating of Lithium Americas (NYSE:LAC) on 5/16/2025 |
AAPL Apple | $201.45
-1.2% | 5/16/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $270.00 -> $270.00 | Low | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 5/16/2025 |
TTWO Take-Two Interactive Software | $233.50
+0.3% | 5/16/2025 | Reiterated by | Wedbush | Analyst Michael Pachter | Outperform -> Outperform | $253.00 -> $269.00 | High | View details for Wedbush rating of Take-Two Interactive Software (NASDAQ:TTWO) on 5/16/2025 |
NUVB Nuvation Bio | $2.51
+1.2% | 5/15/2025 | Reiterated by | Wedbush | Analyst David Nierengarten | Outperform -> Outperform | $5.00 -> $5.00 | Low | View details for Wedbush rating of Nuvation Bio (NYSE:NUVB) on 5/15/2025 |
ZBIO Zenas Biopharma | $11.92
+7.2% | 5/15/2025 | Reiterated by | Wedbush | Analyst M. Fan | Outperform | $35.00 | Medium | View details for Wedbush rating of Zenas Biopharma (NASDAQ:ZBIO) on 5/15/2025 |
MRSN Mersana Therapeutics | $0.39
+1.3% | 5/15/2025 | Reiterated by | Wedbush | - | Outperform | $3.00 | Low | View details for Wedbush rating of Mersana Therapeutics (NASDAQ:MRSN) on 5/15/2025 |
ANRO Alto Neuroscience | $2.55
-0.8% | 5/15/2025 | Reiterated by | Wedbush | Analyst Laura Chico | Neutral -> Neutral | $4.00 -> $4.00 | High | View details for Wedbush rating of Alto Neuroscience (NYSE:ANRO) on 5/15/2025 |
ZNTL Zentalis Pharmaceuticals | $1.49
-2.0% | 5/15/2025 | Reiterated by | Wedbush | Analyst Robert Driscoll | Neutral -> Neutral | $4.00 -> $4.00 | High | View details for Wedbush rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 5/15/2025 |
ORKA Oruka Therapeutics | $12.54
-0.3% | 5/15/2025 | Reiterated by | Wedbush | Analyst Martin Fan | Outperform -> Outperform | $40.00 -> $40.00 | Medium | View details for Wedbush rating of Oruka Therapeutics (NASDAQ:ORKA) on 5/15/2025 |
TOL Toll Brothers | $109.57
+2.1% | 5/15/2025 | Reiterated by | Wedbush | Analyst Jay McCanless | Outperform -> Outperform | $175.00 -> $175.00 | Medium | View details for Wedbush rating of Toll Brothers (NYSE:TOL) on 5/15/2025 |
SDHC Smith Douglas Homes | $20.12
+4.4% | 5/14/2025 | Reiterated by | Wedbush | - | Neutral | $18.00 | High | View details for Wedbush rating of Smith Douglas Homes (NYSE:SDHC) on 5/14/2025 |
SRRK Scholar Rock | $34.07
-0.5% | 5/14/2025 | Reiterated by | Wedbush | - | Outperform | $50.00 | Medium | View details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 5/14/2025 |
DDI DoubleDown Interactive | $10.54
+0.4% | 5/14/2025 | Reiterated by | Wedbush | - | Outperform | $21.00 | Medium | View details for Wedbush rating of DoubleDown Interactive (NASDAQ:DDI) on 5/14/2025 |
RZLT Rezolute | $4.31
-2.7% | 5/14/2025 | Reiterated by | Wedbush | - | Outperform | $12.00 | Medium | View details for Wedbush rating of Rezolute (NASDAQ:RZLT) on 5/14/2025 |
GPRO GoPro | $0.88
+11.2% | 5/13/2025 | Reiterated by | Wedbush | - | Neutral | $1.00 -> $0.75 | High | View details for Wedbush rating of GoPro (NASDAQ:GPRO) on 5/13/2025 |
MLTX MoonLake Immunotherapeutics | $46.62
-0.6% | 5/13/2025 | Reiterated by | Wedbush | - | Outperform | $78.00 -> $80.00 | Low | View details for Wedbush rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 5/13/2025 |
CATX Perspective Therapeutics | $3.23
-2.7% | 5/13/2025 | Reiterated by | Wedbush | - | Outperform | $11.00 | High | View details for Wedbush rating of Perspective Therapeutics (NYSE:CATX) on 5/13/2025 |
IMNM Immunome | $9.27
+1.5% | 5/13/2025 | Reiterated by | Wedbush | - | Outperform | $33.00 -> $21.00 | Medium | View details for Wedbush rating of Immunome (NASDAQ:IMNM) on 5/13/2025 |
LSEA Landsea Homes | $11.28
+0.2% | 5/13/2025 | Reiterated by | Wedbush | Analyst Jay McCanless | Outperform -> Neutral | $15.00 -> $11.30 | High | View details for Wedbush rating of Landsea Homes (NASDAQ:LSEA) on 5/13/2025 |
CTMX CytomX Therapeutics | $2.63
-0.4% | 5/12/2025 | Reiterated by | Wedbush | - | Outperform | $5.00 -> $6.00 | High | View details for Wedbush rating of CytomX Therapeutics (NASDAQ:CTMX) on 5/12/2025 |
STRW Strawberry Fields REIT | $10.21
-1.1% | 5/12/2025 | Reiterated by | Wedbush | - | Outperform | $14.00 -> $13.00 | Low | View details for Wedbush rating of Strawberry Fields REIT (NASDAQ:STRW) on 5/12/2025 |
CVNA Carvana | $340.40
-0.3% | 5/8/2025 | Upgraded by | Wedbush | Analyst S. Devitt | Hold | | Medium | View details for Wedbush rating of Carvana (NYSE:CVNA) on 5/8/2025 |
SOUN SoundHound AI | $10.02
-0.9% | 5/9/2025 | Target Lowered by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $22.00 -> $15.00 | Low | View details for Wedbush rating of SoundHound AI (NASDAQ:SOUN) on 5/9/2025 |
HOWL Werewolf Therapeutics | $1.41
-0.7% | 5/9/2025 | Target Lowered by | Wedbush | Analyst Robert Driscoll | Outperform -> Outperform | $8.00 -> $6.00 | High | View details for Wedbush rating of Werewolf Therapeutics (NASDAQ:HOWL) on 5/9/2025 |
OS Onestream | $28.92
| 5/9/2025 | Target Lowered by | Wedbush | Analyst D. Ives | Outperform -> Outperform | $40.00 -> $35.00 | High | View details for Wedbush rating of Onestream (NASDAQ:OS) on 5/9/2025 |
INOD Innodata | $48.67
-5.0% | 5/9/2025 | Target Lowered by | Wedbush | Analyst D. Ives | Outperform -> Outperform | $75.00 -> $58.00 | Low | View details for Wedbush rating of Innodata (NASDAQ:INOD) on 5/9/2025 |
ALIT Alight | $5.43
-0.5% | 5/9/2025 | Target Lowered by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $11.00 -> $9.00 | Low | View details for Wedbush rating of Alight (NYSE:ALIT) on 5/9/2025 |
RNG RingCentral | $27.41
+0.8% | 5/9/2025 | Target Lowered by | Wedbush | Analyst Daniel Ives | Neutral -> Neutral | $38.00 -> $30.00 | High | View details for Wedbush rating of RingCentral (NYSE:RNG) on 5/9/2025 |
PINS Pinterest | $34.17
-0.1% | 5/9/2025 | Reiterated by | Wedbush | Analyst S. Devitt | Outperform -> Outperform | $38.00 -> $40.00 | High | View details for Wedbush rating of Pinterest (NYSE:PINS) on 5/9/2025 |
TTD Trade Desk | $71.49
+0.0% | 5/9/2025 | Reiterated by | Wedbush | - | Outperform | $80.00 -> $86.00 | High | View details for Wedbush rating of Trade Desk (NASDAQ:TTD) on 5/9/2025 |
RKT Rocket Companies | $12.76
-0.1% | 5/9/2025 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $13.00 -> $12.00 | High | View details for Wedbush rating of Rocket Companies (NYSE:RKT) on 5/9/2025 |
EXPE Expedia Group | $176.62
+0.0% | 5/9/2025 | Reiterated by | Wedbush | - | Neutral | $180.00 -> $165.00 | High | View details for Wedbush rating of Expedia Group (NASDAQ:EXPE) on 5/9/2025 |
U Unity Software | $24.59
-2.1% | 5/7/2025 | Downgraded by | Wedbush | Analyst M. Pachter | Strong-Buy -> Strong Sell | | Low | View details for Wedbush rating of Unity Software (NYSE:U) on 5/7/2025 |
RVMD Revolution Medicines | $40.58
-1.2% | 5/8/2025 | Reiterated by | Wedbush | - | Outperform | $67.00 | Low | View details for Wedbush rating of Revolution Medicines (NASDAQ:RVMD) on 5/8/2025 |
ZG Zillow Group | $69.41
| 5/8/2025 | Reiterated by | Wedbush | - | Outperform | $100.00 -> $90.00 | Medium | View details for Wedbush rating of Zillow Group (NASDAQ:ZG) on 5/8/2025 |
Banks aren’t ready for this altcoin—are you? (Ad) While everyone's distracted by Bitcoin's moves, a stealth revolution is underway.
One altcoin is quietly positioning itself to overthrow the entire banking system. Click here to access the full report now. |
GEO The GEO Group | $27.02
+0.2% | 5/8/2025 | Reiterated by | Wedbush | - | Outperform | $46.00 -> $36.00 | High | View details for Wedbush rating of The GEO Group (NYSE:GEO) on 5/8/2025 |
DBD Diebold Nixdorf | $51.20
+2.4% | 5/8/2025 | Reiterated by | Wedbush | - | Outperform | $60.00 | High | View details for Wedbush rating of Diebold Nixdorf (NYSE:DBD) on 5/8/2025 |
VOR Vor Biopharma | $0.22
-0.4% | 5/8/2025 | Reiterated by | Wedbush | Analyst D. Nierengarten | Outperform -> Neutral | $7.00 -> $0.40 | High | View details for Wedbush rating of Vor Biopharma (NYSE:VOR) on 5/8/2025 |
UBER Uber Technologies | $87.19
+1.9% | 5/8/2025 | Downgraded by | Wedbush | Analyst S. Devitt | Outperform -> Neutral | $80.00 -> $85.00 | Medium | View details for Wedbush rating of Uber Technologies (NYSE:UBER) on 5/8/2025 |
DASH DoorDash | $217.49
-0.4% | 5/7/2025 | Reiterated by | Wedbush | - | Outperform -> Outperform | | Medium | View details for Wedbush rating of DoorDash (NASDAQ:DASH) on 5/7/2025 |
PEB Pebblebrook Hotel Trust | $9.77
+1.7% | 5/6/2025 | Target Set by | Wedbush | Analyst R. Anderson | Underperform -> Underperform | $9.00 | Medium | View details for Wedbush rating of Pebblebrook Hotel Trust (NYSE:PEB) on 5/6/2025 |
PAY Paymentus | $36.15
-0.9% | 5/6/2025 | Target Set by | Wedbush | Analyst D. Ives | Outperform -> Outperform | $40.00 | Medium | View details for Wedbush rating of Paymentus (NYSE:PAY) on 5/6/2025 |
RHP Ryman Hospitality Properties | $98.10
+1.4% | 5/6/2025 | Target Set by | Wedbush | Analyst Jay Kornreich | Outperform -> Outperform | $110.00 | Medium | View details for Wedbush rating of Ryman Hospitality Properties (NYSE:RHP) on 5/6/2025 |
O Realty Income | $56.79
+1.4% | 5/7/2025 | Reiterated by | Wedbush | Analyst Jay Kornreich | Neutral -> Neutral | $61.00 -> $61.00 | Medium | View details for Wedbush rating of Realty Income (NYSE:O) on 5/7/2025 |
VERA Vera Therapeutics | $22.19
-2.2% | 5/7/2025 | Target Lowered by | Wedbush | Analyst Laura Chico | Neutral -> Neutral | $34.00 -> $26.00 | Low | View details for Wedbush rating of Vera Therapeutics (NASDAQ:VERA) on 5/7/2025 |
DNLI Denali Therapeutics | $14.65
-0.3% | 5/7/2025 | Target Lowered by | Wedbush | Analyst Laura Chico | Outperform -> Outperform | $32.00 -> $30.00 | High | View details for Wedbush rating of Denali Therapeutics (NASDAQ:DNLI) on 5/7/2025 |
DASH DoorDash | $217.49
-0.4% | 5/7/2025 | Target Raised by | Wedbush | Analyst Scott Devitt | Neutral -> Neutral | $190.00 -> $200.00 | High | View details for Wedbush rating of DoorDash (NASDAQ:DASH) on 5/7/2025 |
DDOG Datadog | $121.17
-0.8% | 5/7/2025 | Target Lowered by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $155.00 -> $140.00 | Low | View details for Wedbush rating of Datadog (NASDAQ:DDOG) on 5/7/2025 |
IBM International Business Machines | $272.13
+1.2% | 5/7/2025 | Reiterated by | Wedbush | Analyst D. Ives | Outperform -> Outperform | $300.00 -> $300.00 | Low | View details for Wedbush rating of International Business Machines (NYSE:IBM) on 5/7/2025 |
QLYS Qualys | $141.77
-0.1% | 5/7/2025 | Target Lowered by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $160.00 -> $145.00 | High | View details for Wedbush rating of Qualys (NASDAQ:QLYS) on 5/7/2025 |
RIVN Rivian Automotive | $14.40
+2.9% | 5/7/2025 | Target Lowered by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $20.00 -> $18.00 | Low | View details for Wedbush rating of Rivian Automotive (NASDAQ:RIVN) on 5/7/2025 |
EA Electronic Arts | $146.92
-1.8% | 5/7/2025 | Target Raised by | Wedbush | Analyst Michael Pachter | Outperform -> Outperform | $179.00 -> $210.00 | Low | View details for Wedbush rating of Electronic Arts (NASDAQ:EA) on 5/7/2025 |
SMCI Super Micro Computer | $43.12
+3.8% | 5/7/2025 | Reiterated by | Wedbush | Analyst Matt Bryson | Neutral -> Neutral | $40.00 -> $30.00 | High | View details for Wedbush rating of Super Micro Computer (NASDAQ:SMCI) on 5/7/2025 |
DAWN Day One Biopharmaceuticals | $7.08
-1.5% | 5/7/2025 | Reiterated by | Wedbush | - | Outperform | $25.00 | High | View details for Wedbush rating of Day One Biopharmaceuticals (NASDAQ:DAWN) on 5/7/2025 |
RCUS Arcus Biosciences | $9.86
-1.1% | 5/7/2025 | Reiterated by | Wedbush | - | Outperform | $33.00 | High | View details for Wedbush rating of Arcus Biosciences (NYSE:RCUS) on 5/7/2025 |
AMD Advanced Micro Devices | $121.73
+4.8% | 5/7/2025 | Reiterated by | Wedbush | Analyst Matt Bryson | Outperform -> Outperform | $115.00 -> $120.00 | High | View details for Wedbush rating of Advanced Micro Devices (NASDAQ:AMD) on 5/7/2025 |
W Wayfair | $47.41
+4.7% | 5/1/2025 | Upgraded by | Wedbush | Analyst S. Devitt | Hold | | Low | View details for Wedbush rating of Wayfair (NYSE:W) on 5/1/2025 |
MRSN Mersana Therapeutics | $0.39
+1.3% | 5/6/2025 | Reiterated by | Wedbush | - | Outperform | $4.00 -> $3.00 | Low | View details for Wedbush rating of Mersana Therapeutics (NASDAQ:MRSN) on 5/6/2025 |
DFH Dream Finders Homes | $23.19
+5.3% | 5/6/2025 | Reiterated by | Wedbush | - | Neutral | $26.00 | High | View details for Wedbush rating of Dream Finders Homes (NASDAQ:DFH) on 5/6/2025 |
GETY Getty Images | $1.61
-3.0% | 5/6/2025 | Reiterated by | Wedbush | - | Outperform | $7.70 | Low | View details for Wedbush rating of Getty Images (NYSE:GETY) on 5/6/2025 |
TCRX TScan Therapeutics | $1.77
-1.7% | 5/6/2025 | Reiterated by | Wedbush | - | Outperform | $7.00 | High | View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 5/6/2025 |
NBIX Neurocrine Biosciences | $125.73
+0.3% | 5/6/2025 | Reiterated by | Wedbush | - | Outperform | | Low | View details for Wedbush rating of Neurocrine Biosciences (NASDAQ:NBIX) on 5/6/2025 |
PLTR Palantir Technologies | $132.06
+3.4% | 5/6/2025 | Target Set by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $140.00 | Low | View details for Wedbush rating of Palantir Technologies (NASDAQ:PLTR) on 5/6/2025 |
HPP Hudson Pacific Properties | $2.29
-2.8% | 5/5/2025 | Reiterated by | Wedbush | - | Neutral -> Neutral | | Low | View details for Wedbush rating of Hudson Pacific Properties (NYSE:HPP) on 5/5/2025 |
TBCH Turtle Beach | $13.43
+1.8% | 5/6/2025 | Reiterated by | Wedbush | Analyst Michael Pachter | Outperform -> Neutral | $21.00 -> $9.00 | Medium | View details for Wedbush rating of Turtle Beach (NASDAQ:TBCH) on 5/6/2025 |
NFLX Netflix | $1,224.46
-1.4% | 5/5/2025 | Reiterated by | Wedbush | - | Outperform | $1,200.00 | Low | View details for Wedbush rating of Netflix (NASDAQ:NFLX) on 5/5/2025 |
CRSR Corsair Gaming | $9.51
+3.6% | 5/5/2025 | Reiterated by | Wedbush | - | Outperform | $13.00 | High | View details for Wedbush rating of Corsair Gaming (NASDAQ:CRSR) on 5/5/2025 |
SYRE Spyre Therapeutics | $17.16
+1.1% | 5/5/2025 | Reiterated by | Wedbush | - | Outperform | $65.00 | Low | View details for Wedbush rating of Spyre Therapeutics (NASDAQ:SYRE) on 5/5/2025 |
Z Zillow Group | $70.28
0.0% | 5/5/2025 | Reiterated by | Wedbush | Analyst Jay McCanless | Outperform -> Outperform | $100.00 -> $100.00 | Low | View details for Wedbush rating of Zillow Group (NASDAQ:Z) on 5/5/2025 |
HR Healthcare Realty Trust | $14.51
+0.4% | 5/5/2025 | Target Lowered by | Wedbush | Analyst R. Anderson | Neutral -> Neutral | $18.00 -> $16.00 | Low | View details for Wedbush rating of Healthcare Realty Trust (NYSE:HR) on 5/5/2025 |
PRAX Praxis Precision Medicines | $44.51
-0.1% | 5/5/2025 | Target Raised by | Wedbush | Analyst L. Chico | Underperform -> Underperform | $26.00 -> $28.00 | Medium | View details for Wedbush rating of Praxis Precision Medicines (NASDAQ:PRAX) on 5/5/2025 |
VIGL Vigil Neuroscience | $7.88
| 5/5/2025 | Reiterated by | Wedbush | Analyst Laura Chico | Outperform -> Outperform | $13.00 -> $13.00 | Medium | View details for Wedbush rating of Vigil Neuroscience (NASDAQ:VIGL) on 5/5/2025 |
FUBO FuboTV | $3.35
-1.8% | 5/5/2025 | Target Lowered by | Wedbush | Analyst Alicia Reese | Outperform -> Outperform | $6.40 -> $5.00 | High | View details for Wedbush rating of FuboTV (NYSE:FUBO) on 5/5/2025 |
AAPL Apple | $201.45
-1.2% | 5/2/2025 | Downgraded by | Wedbush | - | Outperform -> Neutral | | Low | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 5/2/2025 |
GM General Motors | $47.94
+1.0% | 5/2/2025 | Target Lowered by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $60.00 -> $55.00 | Low | View details for Wedbush rating of General Motors (NYSE:GM) on 5/2/2025 |
AAPL Apple | $201.45
-1.2% | 5/2/2025 | Target Raised by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $250.00 -> $270.00 | Low | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 5/2/2025 |
TVTX Travere Therapeutics | $14.91
-2.7% | 5/2/2025 | Reiterated by | Wedbush | Analyst Laura Chico | Outperform -> Outperform | $30.00 -> $30.00 | High | View details for Wedbush rating of Travere Therapeutics (NASDAQ:TVTX) on 5/2/2025 |
ASND Ascendis Pharma A/S | $173.15
+0.1% | 5/2/2025 | Target Raised by | Wedbush | Analyst Y. Zhong | Outperform -> Outperform | $181.00 -> $212.00 | Low | View details for Wedbush rating of Ascendis Pharma A/S (NASDAQ:ASND) on 5/2/2025 |
PLTK Playtika | $4.81
-1.6% | 5/2/2025 | Reiterated by | Wedbush | - | Outperform | $11.50 | High | View details for Wedbush rating of Playtika (NASDAQ:PLTK) on 5/2/2025 |
BZH Beazer Homes USA | $22.01
+3.0% | 5/2/2025 | Reiterated by | Wedbush | Analyst Jay McCanless | Outperform -> Outperform | $45.00 -> $41.00 | High | View details for Wedbush rating of Beazer Homes USA (NYSE:BZH) on 5/2/2025 |
AMZN Amazon.com | $216.98
+1.6% | 5/2/2025 | Reiterated by | Wedbush | Analyst Scott Devitt | Outperform -> Outperform | $225.00 -> $235.00 | Low | View details for Wedbush rating of Amazon.com (NASDAQ:AMZN) on 5/2/2025 |
ABNB Airbnb | $139.01
-1.2% | 5/2/2025 | Downgraded by | Wedbush | Analyst Scott Devitt | Outperform -> Neutral | $150.00 -> $135.00 | High | View details for Wedbush rating of Airbnb (NASDAQ:ABNB) on 5/2/2025 |
BPMC Blueprint Medicines | $127.97
+0.1% | 5/1/2025 | Reiterated by | Wedbush | - | Outperform | $128.00 | High | View details for Wedbush rating of Blueprint Medicines (NASDAQ:BPMC) on 5/1/2025 |
NCMI National CineMedia | $5.26
+1.3% | 5/1/2025 | Reiterated by | Wedbush | Analyst A. Reese | Outperform | $7.50 | Low | View details for Wedbush rating of National CineMedia (NASDAQ:NCMI) on 5/1/2025 |
ANAB AnaptysBio | $23.19
-2.2% | 5/1/2025 | Reiterated by | Wedbush | Analyst Martin Fan | Outperform -> Outperform | $40.00 -> $40.00 | Low | View details for Wedbush rating of AnaptysBio (NASDAQ:ANAB) on 5/1/2025 |
Trump wipes out trillions overnight… (Ad) Is there anybody more powerful than Donald Trump right now?
In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones…
Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move. Whether you take some of that wealth for yourself depends on if you watch this controversial exposé |
WDC Western Digital | $57.02
+2.8% | 5/1/2025 | Reiterated by | Wedbush | Analyst Matt Bryson | Outperform -> Outperform | $60.00 -> $60.00 | High | View details for Wedbush rating of Western Digital (NASDAQ:WDC) on 5/1/2025 |
TSLA Tesla | $308.58
+4.6% | 5/1/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $350.00 -> $350.00 | Medium | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 5/1/2025 |
MSFT Microsoft | $472.75
+0.5% | 5/1/2025 | Target Raised by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $475.00 -> $515.00 | High | View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 5/1/2025 |
META Meta Platforms | $694.06
-0.5% | 5/1/2025 | Target Raised by | Wedbush | Analyst Meta Marshall | Outperform -> Outperform | $680.00 -> $750.00 | High | View details for Wedbush rating of Meta Platforms (NASDAQ:META) on 5/1/2025 |
STX Seagate Technology | $130.17
+2.5% | 4/30/2025 | Reiterated by | Wedbush | - | Outperform | $150.00 -> $140.00 | High | View details for Wedbush rating of Seagate Technology (NASDAQ:STX) on 4/30/2025 |
XNCR Xencor | $9.55
-1.0% | 4/30/2025 | Reiterated by | Wedbush | - | Outperform | $31.00 | High | View details for Wedbush rating of Xencor (NASDAQ:XNCR) on 4/30/2025 |
U Unity Software | $24.59
-2.1% | 4/30/2025 | Reiterated by | Wedbush | - | Outperform | $31.50 | Low | View details for Wedbush rating of Unity Software (NYSE:U) on 4/30/2025 |
SIMO Silicon Motion Technology | $67.29
+0.3% | 4/30/2025 | Reiterated by | Wedbush | Analyst Matt Bryson | Outperform -> Outperform | $90.00 -> $90.00 | High | View details for Wedbush rating of Silicon Motion Technology (NASDAQ:SIMO) on 4/30/2025 |
AXTI AXT | $1.83
+2.8% | 4/29/2025 | Reiterated by | Wedbush | Analyst Matt Bryson | Outperform -> Outperform | $4.50 -> $4.50 | Low | View details for Wedbush rating of AXT (NASDAQ:AXTI) on 4/29/2025 |
GLPI Gaming and Leisure Properties | $46.84
+0.9% | 4/28/2025 | Target Set by | Wedbush | - | | $55.00 | Low | View details for Wedbush rating of Gaming and Leisure Properties (NASDAQ:GLPI) on 4/28/2025 |
MU Micron Technology | $110.95
+2.2% | 4/28/2025 | Reiterated by | Wedbush | Analyst M. Bryson | Underperform -> Underperform | | Medium | View details for Wedbush rating of Micron Technology (NASDAQ:MU) on 4/28/2025 |
SWTX SpringWorks Therapeutics | $46.75
-0.1% | 4/28/2025 | Reiterated by | Wedbush | Analyst D. Nierengarten | Outperform -> Neutral | $81.00 -> $47.00 | Medium | View details for Wedbush rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 4/28/2025 |
RVMD Revolution Medicines | $40.58
-1.2% | 4/28/2025 | Reiterated by | Wedbush | Analyst Robert Driscoll | Outperform -> Outperform | $67.00 -> $67.00 | Medium | View details for Wedbush rating of Revolution Medicines (NASDAQ:RVMD) on 4/28/2025 |
ROKU Roku | $79.59
+1.4% | 4/28/2025 | Target Lowered by | Wedbush | Analyst Alicia Reese | Outperform -> Outperform | $125.00 -> $100.00 | Low | View details for Wedbush rating of Roku (NASDAQ:ROKU) on 4/28/2025 |
CNK Cinemark | $31.42
-2.2% | 4/28/2025 | Reiterated by | Wedbush | Analyst A. Reese | Neutral -> Neutral | $32.00 -> $32.00 | Low | View details for Wedbush rating of Cinemark (NYSE:CNK) on 4/28/2025 |
FUBO FuboTV | $3.35
-1.8% | 4/28/2025 | Reiterated by | Wedbush | Analyst Michael Pachter | Outperform -> Outperform | $6.40 -> $6.40 | Low | View details for Wedbush rating of FuboTV (NYSE:FUBO) on 4/28/2025 |
DOC Healthpeak Properties | $17.27
+0.0% | 4/28/2025 | Target Lowered by | Wedbush | Analyst Richard Anderson | Outperform -> Outperform | $24.00 -> $22.00 | Low | View details for Wedbush rating of Healthpeak Properties (NYSE:DOC) on 4/28/2025 |
TPH Tri Pointe Homes | $30.66
+2.1% | 4/28/2025 | Upgraded by | Wedbush | Analyst Jay McCanless | Neutral -> Outperform | $38.00 -> $43.00 | Medium | View details for Wedbush rating of Tri Pointe Homes (NYSE:TPH) on 4/28/2025 |
CHKP Check Point Software Technologies | $227.80
-2.4% | 4/24/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $240.00 -> $240.00 | Low | View details for Wedbush rating of Check Point Software Technologies (NASDAQ:CHKP) on 4/24/2025 |
PEGA Pegasystems | $102.04
-0.4% | 4/24/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $125.00 -> $125.00 | High | View details for Wedbush rating of Pegasystems (NASDAQ:PEGA) on 4/24/2025 |
IBM International Business Machines | $272.13
+1.2% | 4/24/2025 | Reiterated by | Wedbush | Analyst D. Ives | Outperform -> Outperform | $300.00 -> $300.00 | Low | View details for Wedbush rating of International Business Machines (NYSE:IBM) on 4/24/2025 |
LOGI Logitech International | $85.98
+0.9% | 4/24/2025 | Reiterated by | Wedbush | Analyst A. Reese | Outperform -> Outperform | $125.00 -> $110.00 | Low | View details for Wedbush rating of Logitech International (NASDAQ:LOGI) on 4/24/2025 |
RBLX Roblox | $93.26
-2.7% | 4/24/2025 | Reiterated by | Wedbush | Analyst M. Pachter | Outperform -> Outperform | $83.00 -> $83.00 | Low | View details for Wedbush rating of Roblox (NYSE:RBLX) on 4/24/2025 |
CCS Century Communities | $53.84
+2.9% | 4/24/2025 | Target Lowered by | Wedbush | Analyst Jay McCanless | Neutral -> Neutral | $93.00 -> $88.00 | High | View details for Wedbush rating of Century Communities (NYSE:CCS) on 4/24/2025 |
TMHC Taylor Morrison Home | $58.03
+1.5% | 4/23/2025 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform -> Outperform | $85.00 -> $85.00 | High | View details for Wedbush rating of Taylor Morrison Home (NYSE:TMHC) on 4/23/2025 |
AMD Advanced Micro Devices | $121.73
+4.8% | 4/23/2025 | Target Lowered by | Wedbush | Analyst Matt Bryson | Outperform -> Outperform | $150.00 -> $115.00 | Medium | View details for Wedbush rating of Advanced Micro Devices (NASDAQ:AMD) on 4/23/2025 |
INTC Intel | $20.48
+2.1% | 4/23/2025 | Target Lowered by | Wedbush | Analyst Matt Bryson | Neutral -> Neutral | $20.00 -> $19.00 | Medium | View details for Wedbush rating of Intel (NASDAQ:INTC) on 4/23/2025 |
TSLA Tesla | $308.58
+4.6% | 4/22/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $315.00 -> $350.00 | N/A | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 4/22/2025 |
PHM PulteGroup | $101.54
+1.3% | 4/22/2025 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform | $135.00 | Low | View details for Wedbush rating of PulteGroup (NYSE:PHM) on 4/22/2025 |
BYON Beyond | $6.64
+2.8% | 4/22/2025 | Reiterated by | Wedbush | - | Outperform | $15.00 | High | View details for Wedbush rating of Beyond (NYSE:BYON) on 4/22/2025 |
NFLX Netflix | $1,224.46
-1.4% | 4/21/2025 | Target Raised by | Wedbush | Analyst Alicia Reese | Outperform -> Outperform | $1,150.00 -> $1,200.00 | Low | View details for Wedbush rating of Netflix (NASDAQ:NFLX) on 4/21/2025 |
EWTX Edgewise Therapeutics | $15.26
+0.1% | 4/21/2025 | Reiterated by | Wedbush | Analyst Laura Chico | Outperform -> Outperform | $43.00 -> $43.00 | Medium | View details for Wedbush rating of Edgewise Therapeutics (NASDAQ:EWTX) on 4/21/2025 |
KMX CarMax | $67.18
+2.2% | 4/21/2025 | Reiterated by | Wedbush | Analyst Seth Basham | Outperform -> Outperform | $90.00 -> $90.00 | Low | View details for Wedbush rating of CarMax (NYSE:KMX) on 4/21/2025 |
WELL Welltower | $150.19
-2.8% | 4/17/2025 | Reiterated by | Wedbush | Analyst R. Anderson | Underperform -> Underperform | | Low | View details for Wedbush rating of Welltower (NYSE:WELL) on 4/17/2025 |
IMAX IMAX | $27.04
-2.2% | 4/17/2025 | Reiterated by | Wedbush | - | Outperform | $32.00 | Low | View details for Wedbush rating of IMAX (NYSE:IMAX) on 4/17/2025 |
RKT Rocket Companies | $12.76
-0.1% | 4/16/2025 | Reiterated by | Wedbush | Analyst J. Mccanless | Hold -> Outperform | $13.00 | Low | View details for Wedbush rating of Rocket Companies (NYSE:RKT) on 4/16/2025 |
KNSA Kiniksa Pharmaceuticals | $30.33
+0.3% | 4/16/2025 | Reiterated by | Wedbush | Analyst David Nierengarten | Outperform -> Outperform | $34.00 -> $34.00 | Low | View details for Wedbush rating of Kiniksa Pharmaceuticals (NASDAQ:KNSA) on 4/16/2025 |
NVCR NovoCure | $16.90
-0.6% | 4/16/2025 | Target Lowered by | Wedbush | Analyst David Nierengarten | Neutral -> Neutral | $29.00 -> $27.00 | Medium | View details for Wedbush rating of NovoCure (NASDAQ:NVCR) on 4/16/2025 |
NVDA NVIDIA | $142.63
+0.6% | 4/16/2025 | Reiterated by | Wedbush | Analyst Matt Bryson | Outperform -> Outperform | $175.00 -> $175.00 | Low | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 4/16/2025 |
BPMC Blueprint Medicines | $127.97
+0.1% | 4/16/2025 | Reiterated by | Wedbush | Analyst David Nierengarten | Outperform -> Outperform | $128.00 -> $128.00 | Medium | View details for Wedbush rating of Blueprint Medicines (NASDAQ:BPMC) on 4/16/2025 |
UMC United Microelectronics | $7.75
+1.5% | 4/16/2025 | Downgraded by | Wedbush | Analyst M. Bryson | Outperform -> Neutral | | Low | View details for Wedbush rating of United Microelectronics (NYSE:UMC) on 4/16/2025 |
META Meta Platforms | $694.06
-0.5% | 4/15/2025 | Target Lowered by | Wedbush | Analyst Meta Marshall | Outperform -> Outperform | $770.00 -> $680.00 | Low | View details for Wedbush rating of Meta Platforms (NASDAQ:META) on 4/15/2025 |
WDC Western Digital | $57.02
+2.8% | 4/11/2025 | Reiterated by | Wedbush | - | Underperform -> Underperform | | Low | View details for Wedbush rating of Western Digital (NASDAQ:WDC) on 4/11/2025 |
SHOP Shopify | $107.80
-3.2% | 4/15/2025 | Reiterated by | Wedbush | Analyst S. Devitt | Outperform -> Outperform | $110.00 | Low | View details for Wedbush rating of Shopify (NYSE:SHOP) on 4/15/2025 |
SE SEA | $164.67
-0.6% | 4/15/2025 | Reiterated by | Wedbush | Analyst Scott Devitt | Outperform -> Outperform | $135.00 | Low | View details for Wedbush rating of SEA (NYSE:SE) on 4/15/2025 |
EXPE Expedia Group | $176.62
+0.0% | 4/15/2025 | Reiterated by | Wedbush | - | Neutral -> Neutral | | Low | View details for Wedbush rating of Expedia Group (NASDAQ:EXPE) on 4/15/2025 |
PINS Pinterest | $34.17
-0.1% | 4/15/2025 | Reiterated by | Wedbush | Analyst S. Devitt | Outperform -> Outperform | | Low | View details for Wedbush rating of Pinterest (NYSE:PINS) on 4/15/2025 |
GOOGL Alphabet | $176.09
+1.4% | 4/15/2025 | Target Set by | Wedbush | Analyst Scott Devitt | Outperform -> Outperform | $190.00 | Low | View details for Wedbush rating of Alphabet (NASDAQ:GOOGL) on 4/15/2025 |
RUM Rumble | $9.36
+1.6% | 4/15/2025 | Target Set by | Wedbush | Analyst Scott Devitt | Neutral -> Neutral | $8.00 | Medium | View details for Wedbush rating of Rumble (NASDAQ:RUM) on 4/15/2025 |
DOC Healthpeak Properties | $17.27
+0.0% | 4/11/2025 | Reiterated by | Wedbush | Analyst Richard Anderson | Outperform -> Outperform | $24.00 -> $24.00 | High | View details for Wedbush rating of Healthpeak Properties (NYSE:DOC) on 4/11/2025 |
Trump wipes out trillions overnight… (Ad) Is there anybody more powerful than Donald Trump right now?
In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones…
Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move. Whether you take some of that wealth for yourself depends on if you watch this controversial exposé |
ARGX argenx | $583.62
-0.4% | 4/11/2025 | Reiterated by | Wedbush | Analyst David Nierengarten | Outperform -> Outperform | $715.00 -> $715.00 | Low | View details for Wedbush rating of argenx (NASDAQ:ARGX) on 4/11/2025 |
KMX CarMax | $67.18
+2.2% | 4/11/2025 | Target Lowered by | Wedbush | Analyst Seth Basham | Outperform -> Outperform | $100.00 -> $90.00 | Low | View details for Wedbush rating of CarMax (NYSE:KMX) on 4/11/2025 |
NFLX Netflix | $1,224.46
-1.4% | 4/11/2025 | Reiterated by | Wedbush | Analyst Alicia Reese | Outperform -> Outperform | $1,150.00 -> $1,150.00 | Medium | View details for Wedbush rating of Netflix (NASDAQ:NFLX) on 4/11/2025 |
MSFT Microsoft | $472.75
+0.5% | 4/10/2025 | Target Lowered by | Wedbush | Analyst D. Ives | Outperform -> Outperform | $550.00 -> $475.00 | High | View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 4/10/2025 |
HR Healthcare Realty Trust | $14.51
+0.4% | 4/7/2025 | Upgraded by | Wedbush | Analyst R. Anderson | Strong Sell -> Hold | | High | View details for Wedbush rating of Healthcare Realty Trust (NYSE:HR) on 4/7/2025 |
KURA Kura Oncology | $6.73
| 4/8/2025 | Reiterated by | Wedbush | - | Outperform | $36.00 | Medium | View details for Wedbush rating of Kura Oncology (NASDAQ:KURA) on 4/8/2025 |
WVE Wave Life Sciences | $7.05
-2.4% | 4/8/2025 | Initiated by | Wedbush | Analyst Y. Zhong | Outperform | $18.00 | High | View details for Wedbush rating of Wave Life Sciences (NASDAQ:WVE) on 4/8/2025 |
AAPL Apple | $201.45
-1.2% | 4/7/2025 | Target Lowered by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $325.00 -> $250.00 | Medium | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 4/7/2025 |
TSLA Tesla | $308.58
+4.6% | 4/7/2025 | Target Lowered by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $550.00 -> $315.00 | High | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 4/7/2025 |
GME GameStop | $30.30
+2.4% | 3/26/2025 | Target Set by | Wedbush | - | | $11.50 | Low | View details for Wedbush rating of GameStop (NYSE:GME) on 3/26/2025 |
CMPX Compass Therapeutics | $2.57
+2.8% | 4/1/2025 | Reiterated by | Wedbush | - | Outperform | $8.00 | High | View details for Wedbush rating of Compass Therapeutics (NASDAQ:CMPX) on 4/1/2025 |
KROS Keros Therapeutics | $14.09
-6.3% | 4/1/2025 | Reiterated by | Wedbush | Analyst Y. Zhong | Neutral -> Neutral | $15.00 -> $15.00 | High | View details for Wedbush rating of Keros Therapeutics (NASDAQ:KROS) on 4/1/2025 |
KMX CarMax | $67.18
+2.2% | 4/1/2025 | Reiterated by | Wedbush | Analyst Seth Basham | Outperform -> Outperform | $100.00 -> $100.00 | Low | View details for Wedbush rating of CarMax (NYSE:KMX) on 4/1/2025 |
PRGS Progress Software | $64.28
+0.2% | 4/1/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $75.00 -> $75.00 | High | View details for Wedbush rating of Progress Software (NASDAQ:PRGS) on 4/1/2025 |
MNRO Monro | $17.26
+6.5% | 4/1/2025 | Target Lowered by | Wedbush | Analyst S. Basham | Outperform -> Outperform | $27.00 -> $19.00 | Medium | View details for Wedbush rating of Monro (NASDAQ:MNRO) on 4/1/2025 |
SAFE Safehold | $15.60
+1.6% | 3/31/2025 | Reiterated by | Wedbush | Analyst Richard Anderson | Neutral -> Neutral | $20.00 -> $20.00 | High | View details for Wedbush rating of Safehold (NYSE:SAFE) on 3/31/2025 |
BROS Dutch Bros | $73.36
+0.4% | 3/31/2025 | Reiterated by | Wedbush | Analyst Nick Setyan | Outperform -> Outperform | $90.00 -> $90.00 | Medium | View details for Wedbush rating of Dutch Bros (NYSE:BROS) on 3/31/2025 |
TYRA Tyra Biosciences | $10.26
-2.7% | 3/28/2025 | Reiterated by | Wedbush | - | Outperform | $30.00 | Medium | View details for Wedbush rating of Tyra Biosciences (NASDAQ:TYRA) on 3/28/2025 |
VRNT Verint Systems | $19.11
+0.1% | 3/28/2025 | Target Lowered by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $38.00 -> $30.00 | Medium | View details for Wedbush rating of Verint Systems (NASDAQ:VRNT) on 3/28/2025 |
TMC TMC the metals | $4.37
+6.6% | 3/28/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Neutral -> Neutral | $4.00 -> $4.00 | High | View details for Wedbush rating of TMC the metals (NASDAQ:TMC) on 3/28/2025 |
RITM Rithm Capital | $11.25
-0.8% | 3/28/2025 | Reiterated by | Wedbush | Analyst Jay McCanless | Outperform -> Outperform | $14.00 -> $14.00 | Low | View details for Wedbush rating of Rithm Capital (NYSE:RITM) on 3/28/2025 |
PTGX Protagonist Therapeutics | $55.68
+2.4% | 3/28/2025 | Reiterated by | Wedbush | Analyst Y. Zhong | Outperform -> Outperform | $70.00 -> $70.00 | Medium | View details for Wedbush rating of Protagonist Therapeutics (NASDAQ:PTGX) on 3/28/2025 |
ZNTL Zentalis Pharmaceuticals | $1.49
-2.0% | 3/28/2025 | Reiterated by | Wedbush | Analyst Robert Driscoll | Neutral -> Neutral | $4.00 -> $4.00 | High | View details for Wedbush rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 3/28/2025 |
TXRH Texas Roadhouse | $194.78
-0.2% | 3/28/2025 | Target Raised by | Wedbush | Analyst Nick Setyan | Outperform -> Outperform | $200.00 -> $210.00 | High | View details for Wedbush rating of Texas Roadhouse (NASDAQ:TXRH) on 3/28/2025 |
NUVB Nuvation Bio | $2.51
+1.2% | 3/27/2025 | Reiterated by | Wedbush | - | Outperform | $5.00 | Medium | View details for Wedbush rating of Nuvation Bio (NYSE:NUVB) on 3/27/2025 |
BCAX Bicara Therapeutics | $11.48
-0.2% | 3/27/2025 | Reiterated by | Wedbush | Analyst D. Nierengarten | Outperform | $31.00 | Low | View details for Wedbush rating of Bicara Therapeutics (NASDAQ:BCAX) on 3/27/2025 |
CHWY Chewy | $46.40
-3.8% | 3/27/2025 | Reiterated by | Wedbush | Analyst Seth Basham | Outperform -> Outperform | $39.00 -> $39.00 | Medium | View details for Wedbush rating of Chewy (NYSE:CHWY) on 3/27/2025 |
WOOF Petco Health and Wellness | $2.64
-5.0% | 3/27/2025 | Target Lowered by | Wedbush | Analyst Seth Basham | Outperform -> Outperform | $6.00 -> $4.00 | High | View details for Wedbush rating of Petco Health and Wellness (NASDAQ:WOOF) on 3/27/2025 |
TSLA Tesla | $308.58
+4.6% | 3/27/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $550.00 -> $550.00 | Medium | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 3/27/2025 |
CATX Perspective Therapeutics | $3.23
-2.7% | 3/26/2025 | Reiterated by | Wedbush | Analyst D. Nierengarten | Outperform -> Outperform | $11.00 -> $11.00 | Medium | View details for Wedbush rating of Perspective Therapeutics (NYSE:CATX) on 3/26/2025 |
RH RH | $184.85
+0.7% | 3/26/2025 | Target Lowered by | Wedbush | Analyst S. Basham | Outperform -> Outperform | $500.00 -> $350.00 | Low | View details for Wedbush rating of RH (NYSE:RH) on 3/26/2025 |
PRPL Purple Innovation | $0.77
+0.1% | 3/26/2025 | Reiterated by | Wedbush | Analyst Seth Basham | Neutral -> Neutral | $1.00 -> $1.00 | Low | View details for Wedbush rating of Purple Innovation (NASDAQ:PRPL) on 3/26/2025 |
RUM Rumble | $9.36
+1.6% | 3/26/2025 | Target Lowered by | Wedbush | Analyst Scott Devitt | Neutral -> Neutral | $13.00 -> $10.00 | Low | View details for Wedbush rating of Rumble (NASDAQ:RUM) on 3/26/2025 |
HURN Huron Consulting Group | $140.02
-2.1% | 3/26/2025 | Target Raised by | Wedbush | Analyst D. Ives | Outperform -> Outperform | $150.00 -> $165.00 | Medium | View details for Wedbush rating of Huron Consulting Group (NASDAQ:HURN) on 3/26/2025 |
APRE Aprea Therapeutics | $1.84
+5.1% | 3/25/2025 | Reiterated by | Wedbush | - | Outperform | $11.00 | Low | View details for Wedbush rating of Aprea Therapeutics (NASDAQ:APRE) on 3/25/2025 |
SRRK Scholar Rock | $34.07
-0.5% | 3/25/2025 | Reiterated by | Wedbush | - | Outperform | $50.00 | High | View details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 3/25/2025 |
KBH KB Home | $52.93
+2.5% | 3/25/2025 | Reiterated by | Wedbush | Analyst Jay McCanless | Neutral -> Neutral | $75.00 -> $75.00 | High | View details for Wedbush rating of KB Home (NYSE:KBH) on 3/25/2025 |
ALIT Alight | $5.43
-0.5% | 3/25/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $11.00 -> $11.00 | Low | View details for Wedbush rating of Alight (NYSE:ALIT) on 3/25/2025 |
OKLO Oklo | $54.63
+8.6% | 3/25/2025 | Reiterated by | Wedbush | Analyst D. Ives | Outperform -> Outperform | $45.00 -> $45.00 | Medium | View details for Wedbush rating of Oklo (NYSE:OKLO) on 3/25/2025 |
ARTV Artiva Biotherapeutics | $2.11
+0.5% | 3/25/2025 | Reiterated by | Wedbush | Analyst Martin Fan | Outperform -> Outperform | $18.00 -> $18.00 | Medium | View details for Wedbush rating of Artiva Biotherapeutics (NASDAQ:ARTV) on 3/25/2025 |
GME GameStop | $30.30
+2.4% | 3/24/2025 | Reiterated by | Wedbush | - | Underperform -> Underperform | $10.00 | Low | View details for Wedbush rating of GameStop (NYSE:GME) on 3/24/2025 |
ELEV Elevation Oncology | $0.38
+20.1% | 3/20/2025 | Downgraded by | Wedbush | Analyst R. Driscoll | Strong-Buy -> Hold | | Low | View details for Wedbush rating of Elevation Oncology (NASDAQ:ELEV) on 3/20/2025 |
ASO Academy Sports and Outdoors | $44.37
+2.1% | 3/21/2025 | Target Lowered by | Wedbush | Analyst Seth Basham | Outperform -> Outperform | $65.00 -> $60.00 | Medium | View details for Wedbush rating of Academy Sports and Outdoors (NASDAQ:ASO) on 3/21/2025 |
DRI Darden Restaurants | $219.75
+1.0% | 3/21/2025 | Target Raised by | Wedbush | Analyst Nick Setyan | Outperform -> Outperform | $220.00 -> $235.00 | Medium | View details for Wedbush rating of Darden Restaurants (NYSE:DRI) on 3/21/2025 |
VOR Vor Biopharma | $0.22
-0.4% | 3/20/2025 | Reiterated by | Wedbush | - | Outperform | $7.00 | High | View details for Wedbush rating of Vor Biopharma (NYSE:VOR) on 3/20/2025 |
GLUE Monte Rosa Therapeutics | $4.92
-1.8% | 3/20/2025 | Reiterated by | Wedbush | Analyst Robert Driscoll | Outperform -> Outperform | $15.00 -> $17.00 | High | View details for Wedbush rating of Monte Rosa Therapeutics (NASDAQ:GLUE) on 3/20/2025 |
ORIC ORIC Pharmaceuticals | $9.86
+5.8% | 3/20/2025 | Reiterated by | Wedbush | - | Outperform | $20.00 | High | View details for Wedbush rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 3/20/2025 |
AVTX Avalo Therapeutics | $4.56
+11.2% | 3/20/2025 | Reiterated by | Wedbush | Analyst R. Driscoll | Outperform | $18.00 | Low | View details for Wedbush rating of Avalo Therapeutics (NASDAQ:AVTX) on 3/20/2025 |
IMNM Immunome | $9.27
+1.5% | 3/20/2025 | Reiterated by | Wedbush | Analyst David Nierengarten | Outperform -> Outperform | $33.00 -> $33.00 | Medium | View details for Wedbush rating of Immunome (NASDAQ:IMNM) on 3/20/2025 |
WSM Williams-Sonoma | $156.78
-0.6% | 3/20/2025 | Target Lowered by | Wedbush | Analyst S. Basham | Neutral -> Neutral | $190.00 -> $170.00 | Medium | View details for Wedbush rating of Williams-Sonoma (NYSE:WSM) on 3/20/2025 |
MSFT Microsoft | $472.75
+0.5% | 3/20/2025 | Reiterated by | Wedbush | Analyst D. Ives | Outperform -> Outperform | $550.00 -> $550.00 | Low | View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 3/20/2025 |
TSLA Tesla | $308.58
+4.6% | 3/20/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $550.00 -> $550.00 | Low | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 3/20/2025 |
ZBIO Zenas Biopharma | $11.92
+7.2% | 3/20/2025 | Initiated by | Wedbush | Analyst Martin Fan | Outperform | $35.00 | Medium | View details for Wedbush rating of Zenas Biopharma (NASDAQ:ZBIO) on 3/20/2025 |
BYON Beyond | $6.64
+2.8% | 3/19/2025 | Reiterated by | Wedbush | - | Outperform | $15.00 | Low | View details for Wedbush rating of Beyond (NYSE:BYON) on 3/19/2025 |
BDTX Black Diamond Therapeutics | $2.48
-3.9% | 3/19/2025 | Reiterated by | Wedbush | - | Outperform | $11.00 | High | View details for Wedbush rating of Black Diamond Therapeutics (NASDAQ:BDTX) on 3/19/2025 |
PRME Prime Medicine | $1.67
-1.2% | 3/18/2025 | Reiterated by | Wedbush | - | Outperform | $12.00 -> $13.00 | High | View details for Wedbush rating of Prime Medicine (NYSE:PRME) on 3/18/2025 |
GEO The GEO Group | $27.02
+0.2% | 3/18/2025 | Reiterated by | Wedbush | - | Outperform | $46.00 | Low | View details for Wedbush rating of The GEO Group (NYSE:GEO) on 3/18/2025 |
CATX Perspective Therapeutics | $3.23
-2.7% | 3/17/2025 | Reiterated by | Wedbush | Analyst D. Nierengarten | Outperform | $11.00 | High | View details for Wedbush rating of Perspective Therapeutics (NYSE:CATX) on 3/17/2025 |
SRRK Scholar Rock | $34.07
-0.5% | 3/17/2025 | Reiterated by | Wedbush | - | Outperform | $50.00 | Medium | View details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 3/17/2025 |
NHI National Health Investors | $71.75
-1.0% | 3/17/2025 | Reiterated by | Wedbush | Analyst Richard Anderson | Outperform -> Outperform | $88.00 -> $88.00 | Low | View details for Wedbush rating of National Health Investors (NYSE:NHI) on 3/17/2025 |
